At Cipher, our business is built on strategic partnerships. We are the link between proven drugs, leading-edge technologies, and the best-connected marketing organizations.

A key objective of our company is to broaden our pipeline. We continue to actively pursue new early stage pipeline products and advance out-licensing discussions for our current products.Our business development team is currently seeking partnerships in North America, South America, and the Pacific Rim.

Galephar Pharmaceutical Research

Cipher has established a strong collaborative partnership with Galephar, a Puerto Rico-based company with oral and pulmonary drug delivery technology, formulation, manufacturing and quality control expertise. Galephar typically works with unique formulations of well-known, active pharmaceutical ingredients. The company's principal owners are Philippe Baudier, President, and Arthur Deboeck, Vice President and General Manager. Their experience in drug delivery and manufacturing R&D spans three decades with a singular focus on galenical research, which is the process of improving the delivery of medications into the body.

Cipher currently has licenses for several medications based on two proprietary drug delivery technologies developed by Galephar. The licensed drug delivery technologies have been applied successfully to a variety of active ingredients.

Kowa Pharmaceuticals America, Inc.

Kowa Pharmaceuticals America, which is headquartered in Montgomery, Alabama, is a privately held specialty pharmaceutical company focused on delivering customer solutions for cardiovascular conditions. Kowa Pharmaceuticals America has the right to market, sell and distribute Lipofen® in the United States.
www.kowapharma.com

Ranbaxy Pharmaceuticals Inc.

Ranbaxy Pharmaceuticals Inc. (Ranbaxy) is a wholly owned subsidiary of Ranbaxy Laboratories Limited, a member of the Daiichi Sankyo Group. Ranbaxy has the right to market, sell and distribute CIP-ISOTRETINOIN in the United States.
www.ranbaxyusa.com

Vertical Pharmaceuticals, Inc.

Founded in 2003, Vertical develops, markets and acquires products with therapeutic options for patients and caregivers. Vertical is a privately owned pharmaceutical company that supplies niche prescription pharmaceutical preparations, specializing in Pain Management, Primary Care, Internal Medicine and Women's Health.
www.verticalpharma.com

Medical Futures Inc.

Medical Futures Inc. is one of Canada's fastest growing pharmaceutical companies that sells both pharmaceutical and natural therapeutic products. Medical Futures has a focus in pain, women's health and gastrointestinal disorders. Founded in 2000, this privately held company is dedicated to advancing the quality of life of all North Americans.
www.medfutures.com